calendar
28,223 catalysts · 17,796 approval · 4,110 device 510k · 2,473 grant · 1,581 device recall · 1,359 device pma · 904 recall
next 91 dayslessmore
MonWedFri
28,223 catalysts · 17,796 approval · 4,110 device 510k · 2,473 grant · 1,581 device recall · 1,359 device pma · 904 recall
Sponsor: ORGANON LLC. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: ORGANON. Form: TABLET. Route: ORAL
Sponsor: HERITAGE PHARMA. Form: TABLET. Route: ORAL
Sponsor: LUPIN LTD. Form: TABLET. Route: ORAL
Sponsor: HALEON US HOLDINGS. Form: CAPSULE. Route: ORAL
Sponsor: ENDO OPERATIONS. Form: IMPLANT. Route: SUBCUTANEOUS
Sponsor: ENDO OPERATIONS. Form: IMPLANT. Route: SUBCUTANEOUS
Sponsor: ENDO OPERATIONS. Form: IMPLANT. Route: SUBCUTANEOUS
Sponsor: CHEPLAPHARM. Form: TABLET. Route: ORAL
Sponsor: CHIESI. Form: INJECTABLE. Route: INTRAVENOUS
Sponsor: UNITED THERAP. Form: SOLUTION. Route: INHALATION
Sponsor: ACTELION. Form: TABLET. Route: ORAL
Sponsor: SPECGX LLC. Form: FILM, EXTENDED RELEASE. Route: TRANSDERMAL
Sponsor: ZYDUS PHARMS USA INC. Form: TABLET. Route: ORAL
Sponsor: AUROBINDO PHARMA. Form: TABLET. Route: ORAL
Sponsor: HIKMA. Form: TABLET. Route: ORAL
Sponsor: TEVA. Form: TABLET. Route: ORAL
Sponsor: PHARMOBEDIENT. Form: TABLET. Route: ORAL
Sponsor: BAYER. Form: TABLET. Route: ORAL
Sponsor: LILLY. Form: INJECTABLE. Route: INJECTION
Sponsor: SUN PHARM INDS LTD. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL
Sponsor: ABBVIE INC. Form: VIAL
Sponsor: JANSSEN PHARMS. Form: INJECTABLE. Route: INJECTION
Sponsor: NOVARTIS. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: NOVARTIS. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: NOVARTIS. Form: TABLET. Route: ORAL
Sponsor: NOVARTIS. Form: TABLET. Route: ORAL
Sponsor: NOVARTIS. Form: SUSPENSION. Route: ORAL
Sponsor: NOVARTIS. Form: SUSPENSION. Route: ORAL
Sponsor: NOVARTIS. Form: SUSPENSION. Route: ORAL
Sponsor: NOVARTIS. Form: SUSPENSION. Route: ORAL
Sponsor: NOVARTIS. Form: SUSPENSION. Route: ORAL
Sponsor: NOVARTIS. Form: SUSPENSION. Route: ORAL
Sponsor: NOVARTIS. Form: SUSPENSION. Route: ORAL
Sponsor: NOVARTIS. Form: SUSPENSION. Route: ORAL
Sponsor: NOVARTIS. Form: SUSPENSION. Route: ORAL
Sponsor: NOVARTIS. Form: TABLET. Route: ORAL
Sponsor: NOVARTIS. Form: TABLET. Route: ORAL
Sponsor: NOVARTIS. Form: TABLET. Route: ORAL
Sponsor: NOVARTIS. Form: TABLET. Route: ORAL
Sponsor: NOVARTIS. Form: TABLET. Route: ORAL
Sponsor: NOVARTIS. Form: TABLET. Route: ORAL
Sponsor: NOVARTIS. Form: TABLET. Route: ORAL
Sponsor: JANSSEN PHARMS. Form: CAPSULE. Route: ORAL
Sponsor: JANSSEN PHARMS. Form: CAPSULE. Route: ORAL
Sponsor: JANSSEN PHARMS. Form: TABLET. Route: ORAL
Sponsor: JANSSEN PHARMS. Form: TABLET. Route: ORAL
Sponsor: PHARMOBEDIENT. Form: TABLET. Route: ORAL
Sponsor: SANDOZ. Form: INJECTABLE. Route: INTRAVENOUS
Sponsor: MYLAN PHARMS INC. Form: TABLET. Route: ORAL